Alaunos Therapeutics Inc.
Organization details
- Legal name
- Alaunos Therapeutics Inc.
- Former names
- Ziopharm Oncology Inc Easyweb Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Fort Lauderdale
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TCRT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001107421
- EIN
- 84-1475642
Board of directors
-
Dale Curtis Hogue Jr. · Director · See RemarksSince 2023
-
Holger Weis · Director · Chief Executive OfficerSince 2023
-
Jaime Vieser · DirectorSince 2023
-
James Huang · DirectorSince 2023
-
Kevin S. Boyle Sr. · Director · Chief Executive OfficerSince 2023
- Since 2023
-
Michael Allen Jerman · DirectorSince 2025
-
Robert Hofmeister · DirectorSince 2023
-
Robert W. Postma · DirectorSince 2023
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 0
-88% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Director election results
Annual meeting of July 3, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
-
100.0%
-
100.0%
Board connections
5 of this board's directors also sit on 10 other boards. 9 are in the same sector.
-
Aktis Oncology Inc. Same sectorvia Mary Thistle
-
Atara Biotherapeutics Inc. Same sectorvia James Huang
-
Connect Biopharma Holdings Limited Same sectorvia James Huang
-
Cullinan Therapeutics Inc. Same sectorvia Mary Thistle
-
Entrada Therapeutics Inc. Same sectorvia Mary Thistle
-
Jupiter Neurosciences Inc. Same sectorvia Holger Weis
-
MIRA Pharmaceuticals Inc. Same sectorvia Michael Allen Jerman
- via Jaime Vieser
-
Q32 Bio Inc. Same sectorvia Mary Thistle
-
Telomir Pharmaceuticals Inc. Same sectorvia Michael Allen Jerman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 6, 2026 | Robert W. Postma Director | Grant or award | +21,829 | $0.74 | $16,250 |
| Oct 6, 2026 | Holger Weis Officer (CEO) | Grant or award | +23,564 | $0.74 | $17,541 |
| Oct 6, 2026 | Jaime Vieser Director | Grant or award | +22,669 | $0.74 | $16,875 |
| Oct 6, 2026 | Michael Allen Jerman Director | Grant or award | +20,990 | $0.74 | $15,625 |
| Aug 6, 2026 | Holger Weis Officer (CEO) | Grant or award | +4,363 | $2.01 | $8,770 |
| Jul 23, 2026 | Jaime Vieser Director | Grant or award | +8,789 | $1.92 | $16,875 |
| Jul 23, 2026 | Robert W. Postma Director | Grant or award | +8,463 | $1.92 | $16,249 |
| Jul 23, 2026 | Holger Weis Officer (CEO) | Grant or award | +4,568 | $1.92 | $8,771 |
| Jul 23, 2026 | Michael Allen Jerman Director | Grant or award | +8,138 | $1.92 | $15,625 |
| Jun 30, 2026 | Holger Weis Officer (Chief Executive Officer) | Grant or award | +3,880 | $2.26 | $8,769 |
| Jun 12, 2026 | Holger Weis Officer (Chief Executive Officer) | Grant or award | +7,761 | $2.26 | $17,540 |
| May 22, 2026 | Holger Weis Officer (Chief Executive Officer) | Grant or award | +3,700 | $2.37 | $8,769 |
| Apr 29, 2026 | Jaime Vieser Director | Grant or award | +6,515 | $2.59 | $16,874 |
| Apr 29, 2026 | Robert W. Postma Director | Grant or award | +6,274 | $2.59 | $16,250 |
| Apr 29, 2026 | Michael Allen Jerman Director | Grant or award | +6,032 | $2.59 | $15,623 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Alaunos Therapeutics Inc.
Who is the CEO of Alaunos Therapeutics Inc.?
Dale Curtis Hogue Jr. has been Alaunos Therapeutics Inc.'s Interim CEO since December 2023.
How many directors are on Alaunos Therapeutics Inc.'s board?
Alaunos Therapeutics Inc.'s board has 9 directors: Dale Curtis Hogue Jr., Holger Weis, Jaime Vieser, James Huang, Kevin S. Boyle Sr., Mary Thistle, Michael Allen Jerman, Robert Hofmeister and Robert W. Postma.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="alaunos-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.